CD4 and hepatocellular carcinoma: Kang et al. found that CD4+ T cells removed senescent premalignant hepatocytes in association with activated monocytes and macrophages (13), which also indicated the importance of immunosurveillance as an anti-HCC barrier in senescence-induced therapy.